IMMUNGENE

immungene-logo

ImmunGene is a privately held biotechnology company focused on the development of proprietary antibody-cytokine fusion technology and monoclonal antibody-based therapies to treat cancer, autoimmune disorders, and other diseases. ImmunGene has several programs at various stages of development. ImmunGene is funded by federal government grants including the NIH-SBIR and by private investors including several biotechnology executives.

#SimilarOrganizations #People #Financial #Website #More

IMMUNGENE

Industry:
Biotechnology Pharmaceutical Therapeutics

Founded:
2007-01-01

Address:
Thousand Oaks, California, United States

Country:
United States

Website Url:
http://www.immungene.com

Total Employee:
11+

Status:
Active

Contact:
8054966700

Total Funding:
9 M USD

Technology used in webpage:
SPF US Privacy User Signal Mechanism Liquid Web Microsoft Azure US East2 Region Microsoft Azure UK South Region Microsoft Authentication Library For JavaScript ParkLogic DNS HTTrack Website Copier Microsoft Azure Japan East Region Microsoft Azure Brazil South Region


Similar Organizations

acertapharma-logo

AcertaPharma

Acerta Pharma provides drug discovery and development services for oncology and autoimmune diseases.

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

alethia-biotherapeutics-logo

Alethia BioTherapeutics

Alethia BioTherapeutics is a biotechnology company developing monoclonal antibody-based therapeutics for cancer-associated diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

fabrus-logo

Fabrus

Fabrus identifies and develops functional therapeutic monoclonal antibodies to challenging cell surface targets like GPCRs and ion channels.

Current Employees Featured

michael-gresser_image

Michael Gresser
Michael Gresser Chief Scientific Officer @ ImmunGene
Chief Scientific Officer

not_available_image

Sanjay D. Khare
Sanjay D. Khare Founder , President and CEO @ ImmunGene
Founder , President and CEO

Founder


not_available_image

Sanjay D. Khare

Investors List

ally-bridge-group_image

Ally Bridge Group

Ally Bridge Group investment in Series A - ImmunGene

Official Site Inspections

http://www.immungene.com Semrush global rank: 7.74 M Semrush visits lastest month: 437

  • Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
  • IP address: 15.197.148.33
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "ImmunGene" on Search Engine